fashion -WSS

fashion

author：explore 2025-09-29 19:57:55 - browse：36919

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

focus

WSS

Life science postdocs should get big pay hike, NIH panel says

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Medicare Advantage overpayments discussion gets experts fired up

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

STAT Virtual Event: JPM Recap, Live!

leisure time

fashion

leisure time

The high cost of giving birth even with insurance

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Apple is now the first public company to be valued at $3 trillion

Psychedelics group wrestles with new pharma identity

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Arena BioWorks launches in Cambridge to speed drug discovery

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Malaria cases in Florida and Texas: Here’s what you need to know

Alkermes shareholders re

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

entertainment

American taxpayers paid $1.8 trillion in health care costs in 2022

In age of alternative facts, a scholarly course on calling out crap

Boston Scientific acquires urology company Axonics for $3.7 billion

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Continuity nursing helped my family in our darkest PICU moments

Gene therapy denied for Afghan refugee whose father aided U.S.

Wikipedia

focus

hotspot

knowledge